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Abstract : Catechins found in green tea, in particular （-）-epigallocatechin-3-gallate 
（EGCG）, have antitumor activity.  The primary antitumor actions of catechins 
are anti-oxidative, anti-angiogenic, and anti-metastatic effects.  Cell migration and 
invasion contribute to the metastatic potential of tumors.  Real-time cell analysis 
（RTCA） measures cell migration and invasion in vitro.  In the present study, using 
RTCA, we investigated whether the cell migration and invasion of oral squamous 
cell carcinomas （OSCCs） of the tongue and oor of the mouth were inhibited by 
EGCG.  Studies were performed using the human SCC-4 and SAS cell lines, which 
are poorly differentiated OSCCs of the tongue, and the HO-1-u-1 cell line, an 
OSCC of the oor of the mouth.  SCC-4 cells exhibited high cell migration and 
invasion compared with the SAS and HO-1-u-1 cells.  EGCG was most effective in 
inhibiting the migration and invasion of SCC-4 cells, and inhibited OSCC cell inva-
sion more strongly than it inhibited cell migration.  EGCG inhibited the expression 
of matrix metalloproteinase （MMP）-2, MMP-9, and integrin α1 and β1 mRNA in 
the OSCC cell lines, particularly SCC-4 cells.  The ndings of the present study 
suggest that EGCG inhibits OSCC cell migration and invasion by inhibiting MMP-
2, MMP-9, and integrin α1 and β1 expression.  Thus, EGCG may be a suitable 
agent or lead compound for the inhibition of OSCC metastasis.
Key words : oral squamous cell carcinoma, migration, invasion, （-）-epigallocatechin-
3-gallate （EGCG）, real-time cell analyzer
Introduction
　Green tea is a popular beverage in Japan.  Because tea contains catechins and polyphenols, it 
may have potential in preventing cancer1）.  A recent study reported a tendency for a reduced 
risk of oral cancer in women who consumed green tea2）.  Catechins are an important constituent 
of green tea and include （-）-epigallocatechin-3-gallate （EGCG）, （-）-epigallocatechin, （-）-epicat-
echin-3-gallate, and （-）-epicatechin3）.  Catechins, especially EGCG, exhibit notable bioactivity in 
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green tea extracts, including antitumor activity and anti-oxidative and anti-angiogenic effects4, 5）. 
Moreover, EGCG acts at numerous points to regulate metastasis, including effects at the DNA, 
RNA, and protein levels6）.
　Oral squamous cell carcinoma （OSCC） is the most common malignancy of the oral cavity 
and has a high incidence of cervical micrometastases7）.  Distant metastases reduce patient quality 
of life and affect the clinical outcome7, 8）.  Increased tumor size and microvascular invasion are 
the most significant independent prognostic factors in predicting the survival of patients with 
OSCC 9）.  Therefore, the presence of metastasis and invasion are the main prognostic factors of 
patients with OSCCs.
　Matrix metalloproteinases （MMPs） are a family of zinc-dependent proteinases that are strongly 
related to cancer metastasis because of their association with extracellular matrix （ECM） 
degradation and cellular migration10）.  In particular, MMP-2 and MMP-9 are highly expressed 
in OSCC compared with normal oral mucosal tissues, and their mRNA and protein levels are 
further increased upon tumor progression11, 12）.  In addition, it is well established that MMP-
2 and MMP-9 are closely associated with tumor invasion and metastasis in a variety of human 
tumors13, 14）.  In a previous study, we reported that EGCG inhibited the mRNA and protein 
expression and activity of MMPs in human umbilical vein endothelial cells co-cultured with bro-
blasts or osteoclasts15, 16）.  Moreover, EGCG inhibits carcinoma cell migration and invasion via 
MMP-2 and MMP-9 17）.  Integrins are transmembrane heterodimeric receptors that interact with 
the ECM.  Expression of integrins and proteases of the MMP and plasminogen activator fami-
lies is altered in both healing and malignant epithelium, and is thus thought to be key in the 
process of re-epithelialization, cell migration, and tumor invasion18, 19）.  EGCG also inhibits the 
activation and expression of integrins17）.  It is therefore thought that EGCG plays an important 
role in inhibition of cancer metastasis by inhibiting MMPs and integrins.
　Previously, we reported on determination of the migration and invasion of OSCCs using 
the xCELLigence real-time cell analysis （RTCA） system （Roche Applied Science, Mannheim, 
Germany）14）.  This system makes use of impedance detection for continuous monitoring of cell 
viability, migration, and invasion20）.  In the present study, we used RTCA to investigate EGCG 
inhibition of the migration and invasion of OSCCs of the tongue and oor of the mouth, as 
well as the expression of associated MMP and integrin mRNA.
Materials and methods
Cell lines and reagents
　The SCC-4 （JCRB9118）21） and SAS （JCRB0260）22） cell lines were both established from 
poorly differentiated OSCC of the tongue.  The HO-1-u-1 cell line （JCRB0828） was established 
from a poorly differentiated OSCC in the oor of the mouth23）.  All three cell lines were pro-
vided by the Health Science Research Resources Bank （Osaka, Japan）.  EGCG was purchased 
from Wako Pure Chemical Industries （Osaka, Japan）.
73EGCG and OSCCs with RTCA
Cell culture
　SAS and HO-1-u-1 cells were cultured at 37°C under a humidified 5％ CO2 and 95％ 
air atmosphere in 45％ Dulbecco’s modified Eagle’s medium with 45％ Ham’s F12 medium 
（DMEM / F12）, 10％ fetal calf serum （FCS）, 100 U / ml penicillin, and 100 µg / ml streptomycin. 
SCC-4 cells, which are undifferentiated cancer cells, were cultured under the same conditions 
in DMEM / F12 with 0.4 µg / ml hydrocortisone, 10％ FCS, 100 U / ml penicillin, and 100 µg / ml 
streptomycin.  The culture medium for all cells was changed every 3 days.
Real-time cell analysis
　The migration and invasion of OSCC cells were analyzed by RTCA, as described previ-
ously14, 24）.  Migration was assessed on an RTCA system CIM-Plate 16 coated with bronectin 
（20 mg / ml）.  SCC-4 cells （1.6 × 105） or 3.2 × 105 SAS or HO-1-u-1 cells were seeded into the 
upper chamber of individual CIM-Plate 16s in 100 µl medium specic for each cell line without 
FCS, and with or without EGCG （10 or 100 µm）.  The upper chamber was then placed on 
the lower chamber of the CIM-Plate 16, which contained growth medium supplemented with 
10％ FCS as an attractant.  Changes in impedance resulting from cells that had migrated to the 
bottom side of the membranes were recorded every 15 min and were monitored for a total of 
48 hr.
　Invasion was assessed using a CIM-plate 16 coated with MatrigelTM （1 : 80 ; BD Biosciences, 
Erembodegem, Belgium） and fibronectin （20 mg / ml）.  SCC-4 cells （1.6 × 105） or 3.2 × 105 
SAS or H0-1-u-1 cells were seeded in the upper chamber of individual CIM-Plate 16s in 100 µl 
medium specic for each cell line without FCS, and with or without EGCG （10, 20, or 100 µm）. 
The upper chamber was then placed on the lower chamber of the CIM-Plate 16 containing 
growth medium supplemented with 10％ FCS as an attractant.  Changes in impedance resulting 
from cells that had migrated to the bottom side of the membranes were recorded every 15 min 
and were monitored for a total of 48 hr.
　A unitless parameter termed cell index was used to measure the relative change in electri-
cal impedance as a marker of cell status.  The cell index is a relative and dimensionless value 
because it represents the impedance change divided by a background value.
RNA isolation and quantitative real-time reverse transcription-polymerase chain reaction
　OSCC cells were seeded in six-well plates, grown for 1 week at 37°C, and then treated with 
EGCG （0, 10 and 100 µm） for 5 hr.  Quantitative polymerase chain reaction （qPCR） was used 
to quantify mRNA levels of MMP-2, MMP-9, and integrin α1 and β1 in OSCC cells.  Total 
RNA was extracted using NucleoSpin RNA II （MACHEREY-NAGEL, Duren, Germany） and 
reverse transcribed using the PrimeScript RT Master Mix （TaKaRa Bio, Shiga, Japan）.  The 
resulting cDNAs were amplified using primers designed using ProbeFiber software （Roche）. 
Table 1 lists the primers used, the Roche Universal ProbeLibrary probe numbers, and the gene 
accession numbers.  Amplication was performed with a LightCycler （Roche） using the Light-
Cycler TaqMan Master mix （Roche）.  The PCR reaction parameters were as follows : 95°C for 
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10 min, followed by 45 cycles （except for 18s rRNA amplication＝25 cycles） of 10 sec at 95°C, 
30 sec at 60°C, and 1 sec at 72°C.  Fluorescence data were analyzed using LightCycler software 
（Roche）.  mRNA levels of the genes of interest were normalized against those of 18s rRNA 
used as an internal standard to yield relative expression ratios14）.
Statistical analysis
　The normal distribution of baseline variables for all RTCA data was evaluated using the Bon-
ferroni test following one-way analysis of variance （ANOVA）.  PCR data were analyzed using 
the two-sided Mann–Whitney U-test.  All data are expressed as the mean ± SEM.  P＜ 0.05 was 
considered signicant.
Results
　Fig. 1 shows the results of RTCA of the effect of EGCG on cell invasion through Matrigel TM- 
and fibronectin-coated invasion chambers.  EGCG was added to the upper chamber of the 
invasion apparatus at a concentration of 10 or 100 µm and inhibited the invasion of OSCCs in 
a concentration-dependent manner.  After 18 hr incubation, the cell index for control, 10, and 
100 µm EGCG-treated SCC-4 cells was 3.66 ± 0.10 （n＝10）, 0.17 ± 0.12 （n＝7）, and 0.02 ±
0.02 （n＝7）, respectively.  EGCG treatment resulted in an approximate 100％ inhibition of cell 
invasion for up to 18 hr after EGCG addition （Fig. 1A）.  At 48 hr after EGCG addition, the 
invasion of SCC-4 cells was inhibited by 98.7％ in the presence of 100 µm EGCG （P＜ 0.01 
vs control and 10 µm EGCG） and by 76.3％ in the presence of 10 µm EGCG （P ＜ 0.01 vs 
control ; Fig. 1A）.  The invasion of SAS cells was decreased by 93.2％ after 24 hr exposure to 
100 µm EGCG （P ＜ 0.01 vs control and 10 µm EGCG） and by 63.4％ after 48 hr exposure 
to 10 µm EGCG （P ＜ 0.01 vs control ; n＝10 wells ［control］ and 6 wells ［10 and 100 µm 
EGCG treatment］; Fig. 1B）.  The invasion of HO-1-u-1 cells was decreased by 92.7％ after 24 hr 
Table 1.  Nucleotide sequences of primers used for polymerase chain reaction
Gene Sequence Accession no. Probe no.
MMP-2 Sense : 5’-gagggggcaggtcatgtag-3’ AY738117.1
#58
Antisense : 5’-ggctggatgagatcttgctg-3’ AY738117.1
MMP-9 Sense : 5’-gaaccaatctcaccgacagg-3’ NM_004994.2
#6
Antisense : 5’-gccacccgagtgtaaccata-3’ NM_004994.2
Integrin α1 Sense : 5’-aattggctctagtcaccattgtt-3’ NM_181501.1
#14
Antisense : 5’-caaatgaagctgctgactggt-3’ NM_181501.1
Integrin β1 Sense : 5’-cgatgccatcatgcaagt-3’ NM_002211.3
#65
Antisense : 5’-acaccagcagccgtgtaac-3’ NM_002211.3
18s Sense : 5’-gcaattattccccatgaacg-3’ X03205.1
#48
Antisense : 5’-gggacttaatcaacgcaagc-3’ X03205.1
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exposure to 100 µm EGCG （P＜ 0.05 vs control and 10 µm EGCG） and by 57.4％ after 48 hr 
exposure to 10 µm EGCG （P ＜ 0.01 vs control ; n＝10 wells ［control］ and 5 wells ［10 and 
100 µm EGCG］; Fig. 1C）.
　Fig. 2 shows the effect of EGCG on cell migratory responses on a bronectin substrate as 
determined using RTCA.  EGCG was added to the upper chamber of the migration apparatus 
at a concentration of 10, 20, or 100 µm.  The migration of SCC-4 cells was decreased by 99.9％ 
following 48 hr treatment with 100 µm EGCG （P＜ 0.01 vs control and 10 and 20 µm EGCG） 
and by 55.1％ after 48 hr exposure to 10 µm EGCG （P＜ 0.01 vs control ; n＝10 wells ［control］ 
and 7 wells ［10, 20, and 100 µm EGCG］; Fig. 2A）.  The migration of SAS cells decreased by 
95.7％ following 48 hr treatment with 100 µm EGCG （P＜ 0.01 vs control and 10 and 20 µm 
EGCG） and by 16.6％ after 48 hr exposure to 10 µm EGCG （P＜ 0.01 vs control and 20 and 
100 µm EGCG ; n＝10 wells ［control］, 6 wells ［10 and 100 µm EGCG］, and 7 wells ［20 µm 
EGCG］; Fig. 1B）.  The migration of HO-1-u-1 cells was decreased by 93.9％ following 48 hr 
treatment with 100 µm EGCG （P＜ 0.01 vs control and 10 and 20 µm EGCG）, but there was 
no signicant difference in migration between the control and 10 µm EGCG-treated groups after 
48 hr （n＝10 wells ［control］, 5 wells ［10 and 100 µm EGCG］, and 7 wells ［20 µm EGCG］; 
Fig. 2C）.  In the case of SCC-4 cells, the effects of EGCG on the invasion response were simi-
lar to its effects on the migratory response.  However, in the case of SAS and HO-1-u-1 cells, 
EGCG induced a greater decrease in cell invasion than cell migratory responses, particularly at a 
concentration of 10 µm.
　Fig. 3 and 4 show MMP-2 and MMP-9 mRNA expression in OSCCs after 5 hr exposure to 
EGCG.  In these experiments, control expression was set at 100％.  Treatment of SCC-4 cells 
with 100 µm EGCG induced a 52.9％ decrease in MMP-2 mRNA expression compared with 
control （P＜ 0.05 ; n＝6 for all ; Fig. 3A）.  However, EGCG had no signicant effect on MMP-
2 mRNA levels in SAS and HO-1-u-1 cells （n＝4 for all ; Fig. 3B, C）.  Treatment of SCC-4 cells 
with 10 and 100 µm EGCG resulted in a 60.7％ and 67.0％ decrease in MMP-9 mRNA levels, 
respectively, compared with control （P＜ 0.05 for both ; n＝6 for all ; Fig. 4A）.  Similarly, EGCG 
（10 and 100 µm） treatment of HO-1-u-1 cells decreased MMP-9 mRNA expression by 43.8％ 
and 55.0％, respectively, compared with control （P ＜ 0.05 for both ; n＝4 for all ; Fig. 4C）. 
There was a tendency for MMP-9 mRNA levels to decrease in SAS cells following EGCG treat-
ment compared with control （n＝4 for all ; Fig. 4B）.
　Fig. 5 and 6 show integrin α1 and β1 mRNA expression in OSCC cells after 5 hr treatment 
with EGCG.  EGCG treatment （100 µm） of SCC-4 （Fig. 5A ; n＝4） and HO-1-u-1 （Fig. 5C ; n＝6） 
cells decreased integrin α1 mRNA levels to 32.6％ and 45.5％ of control, respectively （P＜ 0.05 for 
both）.  There was a tendency for decreased integrin α1 mRNA expression in 100 µm EGCG-
treated SAS cells compared with control （n＝4 for all ; Fig. 5B）.  Integrin β1 mRNA levels in 
SCC-4 cells were decreased by 58.5％ and 60.4％ compared with control following treatment 
with 10 and 100 µm EGCG, respectively （P ＜ 0.01 for both ; n＝6 ; Fig. 6A）.  Treatment of 
SAS and HO-1-u-1 cells with 100 µm EGCG decreased integrin β1 mRNA levels by 64.7％ and 
69.8％, respectively, compared with control （P＜ 0.05 for both ; n＝4 for all ; Fig. 6B, C）.
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Fig. 2.  EGCG inhibition of migration
Migration of （A） SCC-4, （B） SAS, and （C） HO-1-u-1 cell lines over fibronectin was analyzed using real-time cell 
analysis. Cells were seeded into wells of a CIM-Plate 16 （1.6 × 105 SCC-4 cells / well ; 3.2 × 105 SAS and HO-1-u-1 
cells / well） and were allowed to migrate in the absence （Control ; blue） or presence of 10 （red）, 20 （green）, or 
100 µm （purple） （-）-epigallocatechin-3-gallate （EGCG） added to the upper compartment of each well. Data are the 
mean ± SEM cell index （CI） of n wells （n＝10 ［control］ and 7 ［10, 20, and 100 µm EGCG］ in A ; n＝10 ［control］, 
6 ［10 and 100 µm EGCG］, and 7 ［20 µm EGCG］ in B ; and n＝10 ［control］, 5 ［10 and 100 µm EGCG］, and 7 
［20 µm EGCG］ in C）. ＊P＜ 0.05, ＊＊P＜ 0.01 compared with control ; †P＜ 0.05, ††P＜ 0.01 compared with 10 µm 
EGCG ; ‡P＜ 0.05, ‡‡P＜ 0.01 compared with 20 µm EGCG.
Fig. 1.  EGCG inhibition of invasion
Invasion of （A） SCC-4, （B） SAS, and （C） HO-1-u-1 cell lines through Matrigel TM and fibronectin was analyzed 
using real-time cell analysis. Cells were seeded into wells of a CIM-Plate 16 （1.6 × 105 SCC-4 cells / well ; 3.2 × 105 
SAS and HO-1-u-1 cells / well） and were allowed to migrate in the absence （Control） or presence of 10 or 100 µm 
（-）-epigallocatechin-3-gallate （EGCG） added to the upper compartment of each well. Data are the mean ± SEM 
cell index （CI） of n wells （n＝10 ［control］ and 7 ［10 and 100 µm EGCG］ in A ; n＝10 ［control］ and 6 ［10 and 
100 µm EGCG］ in B ; and n＝10 ［control］ and 5 ［10 and 100 µm EGCG］ in C）. ＊P＜ 0.05, ＊＊P＜ 0.01 compared 
with control ; †P＜ 0.05, ††P＜ 0.01 compared with 10 µm EGCG.
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Fig. 3.  Effect of EGCG on MMP-2 mRNA expression of oral squamous cell carcinoma cells
Matrix metalloproteinase （MMP）-2 mRNA expression in （A） SCC-4, （B） SAS, and （C） HO-1-u-1 
cell lines, as determined by quantitative polymerase chain reaction. Expression of MMP-2 mRNA 
was normalized against that of 18s rRNA, used as an internal control. Expression in the control 
group was set at 100％ and expression in the remaining groups is shown relative to the control 
group. Data are the mean ± SEM （n＝6 for all groups in A ; n＝4 for all groups in B and C）. 
＊P＜ 0.05 compared with control.
Fig. 4.  Effect of EGCG on MMP-9 mRNA expression of oral squamous cell carcinoma cells
Matrix metalloproteinase （MMP）-9 mRNA expression in （A） SCC-4, （B） SAS, and （C） HO-1-u-1 
cell lines, as determined by quantitative polymerase chain reaction. Expression of MMP-9 mRNA 
was normalized against that of 18s rRNA, used as an internal control. Expression in the control 
group was set at 100％ and expression in the remaining groups is shown relative to the control 
group. Data are the mean ± SEM （n＝6 for all groups in A ; n＝4 for all groups in B and C）. 
＊P＜ 0.05 compared with control.
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Fig. 5.  Effect of EGCG on integrin α1 mRNA expression of oral squamous cell carcinoma cells
Integrin α1 mRNA expression in （A） SCC-4, （B） SAS, and （C） HO-1-u-1 cell lines, as determined 
by quantitative polymerase chain reaction. Expression of integrin α1 mRNA was normalized against 
that of 18s rRNA, used as an internal control. Expression in the control group was set at 100％ 
and expression in the remaining groups is shown relative to the control group. Data are the mean 
± SEM （n＝6 for all groups in A ; n＝4 for all groups in B and C）. ＊P＜ 0.05 compared with 
control.
Fig. 6.  Effect of EGCG on integrin β1 mRNA expression of oral squamous cell carcinoma cells
Integrin β1 mRNA expression in （A） SCC-4, （B） SAS, and （C） HO-1-u-1 cell lines, as 
determined by quantitative polymerase chain reaction. Expression of integrin β1 mRNA was 
normalized against that of 18s rRNA, used as an internal control. Expression in the control group 
was set at 100％ and expression in the remaining groups is shown relative to the control group. 
Data are the mean ± SEM （n＝6 for all groups in A ; n＝4 for all groups in B and C）. ＊P＜
0.05, ＊＊P＜ 0.01 compared with control.
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Discussion
　In the present study, using RTCA, we demonstrated that EGCG inhibited the migratory and 
invasion responses of poorly differentiated OSCC cell lines and that these responses were associ-
ated with changes in MMP-9 and integrin α1 in real time.  The use of RTCA facilitated the 
capture of the effects of EGCG on each of the three types of OSCC cells.
　A frequent problem associated with the use of EGCG as an anticancer agent is its low blood 
concentrations.  Lee et al. reported that locally high concentrations of tea polyphenols （Cmax＝
131.0–2.2 µm） could be achieved by holding green tea leaves in the oral cavity25）.  In the present 
study, using RTCA, we demonstrated that 100 µm EGCG clearly inhibits cell migratory and inva-
sion responses ; these ndings suggest that EGCG has the potential to be effective against cancer 
cells.  However, it will be difcult to immediately use EGCG as a clinical treatment because the 
route of administration and dosage need to be established.
　MMP-2 and MMP-9 are important targets for the prevention of cancer migration and inva-
sion26）.  This is because the cancer cell-matrix interaction is a critical step in the promotion 
of cell migration27）, and proteolytic degradation of the ECM is a crucial event during tumor 
invasion and metastasis.  This role of MMPs explains why the invasion and migration of OSCC 
cell lines were inhibited by EGCG-induced downregulation of MMP-2 and MMP-9 production 
in the present study.  In a previous study, using the broad-spectrum MMP inhibitor marimastat, 
we demonstrated that MMPs are associated with the invasion and metastasis of OSSCs14）. 
Moreover, it is known that EGCG inhibits the mRNA expression and activity of MMP-2 and 
MMP-9 15, 16）.  SCC-4 cells expressed much higher levels of MMP than SAS and HO-1-u-1 cells. 
It is therefore interesting that MMP-2 and MMP-9 mRNA levels and the tumor invasion and 
migration of SCC-4 cells were more strongly inhibited by EGCG than those of SAS and HO-
1-u-1 cells.  The differences in the inhibitory effects of EGCG on the different cell lines were 
particularly strong for the effects of 10 µm EGCG on tumor invasion and migration.  Moreover, 
in the present study EGCG inhibited the invasion of the OSCC cell lines more effectively 
than it inhibited their migration.  The greater effect of EGCG on cell invasion, as determined 
using the RTCA, may be due to the fact that MMP-2 and MMP-9 appear to be necessary for 
degradation of the Matrigel TM during tumor invasion.  No effect of EGCG on MMP-2 mRNA 
expression in SAS or HO-1-u-1 cells was observed.  However, EGCG has been shown previously 
to affect MMP activity, in particular MMP-2 activity, both directly and indirectly at relatively low 
doses （10–20 µm）16）.
　The α- and β-subunits of integrins contribute to the formation of the ligand-binding pocket. 
However, the α-subunit is likely to play an important role in determining binding selectivity 
because integrin heterodimers often share a common β-subunit but have a distinct α chain and 
bind different ligands28）.  Coordinated cellular responses to ECM attachment that are mediated 
by integrins have been shown to induce tumor cell metastasis29）.  Sen and Chatterjee reported 
that integrin-mediated signaling is necessary for epidermal growth factor （EGF）-mediated 
responses and that integrins collaborate with EGF in the phosphorylation and enhancement 
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of activation of tyrosine kinases, such as focal adhesion kinase （FAK） and extracellular signal-
regulated kinase （ERK）30）.  EGCG inhibits the cooperative responses of integrin and growth 
factor receptors30）.  In the present study, we showed that EGCG reduced integrin α1 and β1 
mRNA expression in OSCC cell lines.
　In conclusion, using RTCA technology, we clearly showed EGCG-induced inhibition of the 
migratory and invasion responses of poorly differentiated OSCC cell lines in real time.  The 
results suggest that EGCG may be a suitable agent or lead compound for the inhibition of 
metastases of OSCCs by inhibiting MMPs and integrins.
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